ThinkSabio

$MRNA

$212.00▲ -0.7% YTD

18 SEC 13D/G filings tracked · Last updated Oct 13, 2026

Filing History
News
MRNA ▼ -0.7% - Moderna, Inc.
CP $212.00▲ -0.7%Oct 13, 2026 · ThinkSabio Blog

$MRNA - Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026…

News
MRNA ▲ +8.8% - Moderna, Inc.
CP $214.41▲ +8.8%Oct 9, 2026 · ThinkSabio Blog

$MRNA NVAX highs…

News
MRNA ▲ +6.6% - Moderna, Inc.
CP $202.78▲ +6.6%Oct 5, 2026 · ThinkSabio Blog

$MRNA BNTX NVAX highs…

News
MRNA ▲ +4.5% - Moderna, Inc.
CP $198.70▲ +4.5%Oct 5, 2026 · ThinkSabio Blog

$MRNA highs following continue covid and Russia "plague" talk…

News
MRNA ▼ -1.7% - Moderna, Inc.
CP $189.19▲ -1.7%Oct 2, 2026 · ThinkSabio Blog

$MRNA Moderna to join Nasdaq-100 Index…

News
MRNA ▼ -6.3% - Moderna, Inc.
CP $190.60▲ -6.3%Sep 30, 2026 · ThinkSabio Blog

$MRNA - Moderna Adds Chief Operating Officer Role as Company Expands into Oncology…

News
MRNA ▼ -4.2% - Moderna, Inc.
CP $195.00▲ -4.2%Sep 30, 2026 · ThinkSabio Blog

$MRNA d/g Sell @ Citi Citi analyst Geoff Meacham downgraded Moderna to Sell from Neutral with a price target of $80, up from $60. The firm cites valua…

News
MRNA ▲ +8.6% - Moderna, Inc.
CP $167.33▲ +8.6%Sep 21, 2026 · ThinkSabio Blog

$MRNA - Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026…

News
MRNA ▲ +7.2% - Moderna, Inc.
CP $146.46▲ +7.2%Sep 11, 2026 · ThinkSabio Blog

$MRNA some vol…

News
MRNA ▼ -2.3% - Moderna, Inc.
CP $147.36▲ -2.3%Sep 3, 2026 · ThinkSabio Blog

$MRNA d/g Sell @ Redburn pt 81 The firm calls the Phase 3 melanoma vaccine result “a great result,” but says the stock now appears to price in broad u…

News
MRNA ▼ -1.6% - Moderna, Inc.
CP $138.11▲ -1.6%Sep 1, 2026 · ThinkSabio Blog

$MRNA - Moderna to Present at Upcoming Conferences in September 2026…

News
MRNA ▲ +1.1% - Moderna, Inc.
CP $144.32▲ +1.1%Aug 28, 2026 · ThinkSabio Blog

$MRNA - Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes…

News
MRNA ▼ -5.3% - Moderna, Inc.
CP $141.68▲ -5.3%Aug 27, 2026 · ThinkSabio Blog

$MRNA - Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines…

News
MRNA ▼ -5.6% - Moderna, Inc.
CP 141.35▲ -5.6%Aug 27, 2026 · ThinkSabio Blog

$MRNA TO RAISE $2B THROUGH CONVERTIBLE SENIOR NOTES DUE 2032, WITH AN OPTION FOR AN ADDITIONAL $300M…

News
MRNA ▼ -5.6% - Moderna, Inc.
CP 141.35▲ -5.6%Aug 27, 2026 · ThinkSabio Blog

$MRNA down pm…

News
MRNA ▼ -5.6% - Moderna, Inc.
CP 141.35▲ -5.6%Aug 27, 2026 · ThinkSabio Blog

$MRNA - Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes…

SEC 13D/G
MRNA - Moderna, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified
$54.55▲ 76.71%Aug 6, 2026 · ThinkSabio Blog

$MRNA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MRNA Moderna, Inc. : $54.55 Sector: Healthcare | YTD: 🔼+ 76.71%…

SEC 13D/G
$MRNA SEC Filing Update (24-JUL-2026) | ThinkSabio - Stocks Simplified
$55.99▲ 81.37%Jul 24, 2026 · ThinkSabio Blog

$MRNA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MRNA : $55.99 Sector: Healthcare | YTD: 🔼+ 81.37% The SEC discl…